KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Short term Debt: 2013-2014

  • Palvella Therapeutics' Short term Debt rose 515.33% to $1.3 million in Q4 2014 from the same period last year, while for Dec 2014 it was $1.3 million, marking a year-over-year increase of 515.33%. This contributed to the annual value of $1.3 million for FY2014, which is 515.33% up from last year.
  • Per Palvella Therapeutics' latest filing, its Short term Debt stood at $1.3 million for Q4 2014, which was up 515.33% from $206,490 recorded in Q4 2013.
  • Palvella Therapeutics' Short term Debt's 5-year high stood at $1.3 million during Q4 2014, with a 5-year trough of $206,490 in Q4 2013.
  • In the last 2 years, Palvella Therapeutics' Short term Debt had a median value of $738,548 in 2013 and averaged $738,548.
  • Data for Palvella Therapeutics' Short term Debt shows a peak YoY spiked of 515.33% (in 2014) over the last 5 years.
  • Quarterly analysis of 2 years shows Palvella Therapeutics' Short term Debt stood at $206,490 in 2013, then skyrocketed by 515.33% to $1.3 million in 2014.